Industry

CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), today announced that it has been selected to conduct an oral presentation covering the novel THIO platform at the XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids, which will be taking place in Stockholm, Sweden on … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Molecular Diagnostics Devices And Equipment Market Report 2022” report has been added to ResearchAndMarkets.com’s offering. The global molecular diagnostics devices and equipment market is expected to grow from $24.19 billion in 2021 to $27.91 billion in 2022 at a compound annual growth rate (CAGR) of 15.3%. The market is expected to grow … [Read more…]

DETROIT–(BUSINESS WIRE)–Together Women’s Health (“TWH” or “the Company”) is pleased to announce it has entered the Illinois market with the affiliation of both Northwestern Specialists for Women (“NSW”) and North Shore Associates in Gynecology and Obstetrics (“NSAGO”), adding 22 providers and three locations to the TWH network. Together Women’s Health is a women’s health focused … [Read more…]

FLOWER MOUND, Texas–(BUSINESS WIRE)–Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.20 per share of common stock, payable on Wednesday, September 28, 2022, to shareholders of record at the close of business on … [Read more…]

– Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across three dose cohorts in the six treated patients – The five longest treated patients exhibited elevated α-Gal A activity, ranging from nearly 3-fold to nearly 17-fold above mean normal, up to 15 months as at the last date of measurement – One patient … [Read more…]

Vivani will be traded under the new ticker (Nasdaq: VANI) LOS ANGELES–(BUSINESS WIRE)–Second Sight Medical Products, Inc.(NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, announced today the completion of its merger with Nano Precision Medical, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bioinformatics – Market Insights, Competitive Landscape and Market Forecast-2027” report has been added to ResearchAndMarkets.com’s offering. The global bioinformatics market was valued at USD 20.12 Billion in 2021, growing at a CAGR of 15.14% during the forecast period from 2022 to 2027 to reach USD 46.88 Billion by 2027. Companies Mentioned Agilent Technologies … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Logistics Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The Global Pharmaceutical Logistics market size is expected to show an annual growth rate of approximately 5% during the forecast period 2022-2027. Companies Mentioned Deutsche Post DHL Kuehne + Nagel UPS (Marken) … [Read more…]

Oncomine Dx Express Test and Oncomine Reporter Dx informatics combine with Ion Torrent Genexus Dx System to deliver clinically relevant biomarker results in as little as one day CARLSBAD, Calif.–(BUSINESS WIRE)–Next-generation sequencing (NGS) is quickly becoming the platform of choice for tumor molecular profiling due to its ability to simultaneously report on multiple biomarkers. However, … [Read more…]

The Phase 2 trial for the treatment of NASH met its primary efficacy endpoint; PXL065-treated patients achieved statistically significant improvements in the relative decrease in liver fat content measured by magnetic resonance imaging estimated proton density fat fraction (MRI-PDFF) at 36-weeks for all doses. Key secondary measures in PXL065-treated patients included a statistically significant improvement … [Read more…]